Compare · RKDA vs UVV
RKDA vs UVV
Side-by-side comparison of Arcadia Biosciences Inc. (RKDA) and Universal Corporation (UVV): market cap, price performance, sector, and recent activity on the wire.
Summary
- RKDA operates in Consumer Staples, while UVV operates in Industrials - the two are in different parts of the market.
- UVV is the larger of the two at $1.32B, about 643.2x RKDA ($2.1M).
- UVV has been more active in the news (12 items in the past 4 weeks vs 3 for RKDA).
- RKDA has more recent analyst coverage (1 ratings vs 0 for UVV).
- Company
- Arcadia Biosciences Inc.
- Universal Corporation
- Price
- -
- -
- Market cap
- $2.1M
- $1.32B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Farming/Seeds/Milling
- Farming/Seeds/Milling
- Exchange
- NASDAQ
- NYSE
- IPO
- 2015
- News (4w)
- 3
- 12
- Recent ratings
- 1
- 0
Arcadia Biosciences Inc.
Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.
Universal Corporation
Universal Corporation processes and supplies leaf tobacco and plant-based ingredients worldwide. The company operates through two segments, Tobacco Operations and Ingredients Operations. It is involved in procuring, financing, processing, packing, storing, and shipping leaf tobacco for sale to manufacturers of consumer tobacco products. The company contracts, purchases, processes, and sells flue-cured, burley, and oriental tobaccos that are primarily used in the manufacture of cigarettes; and dark air-cured tobaccos principally used in the manufacture of cigars, natural wrapped cigars and cigarillos, smokeless, and pipe tobacco products. It also provides value-added services, including blending, chemical, and physical testing of tobacco; service cutting for various manufacturers; manufacturing reconstituted leaf tobacco; just-in-time inventory management services; electronic nicotine delivery systems; and smoke testing services for customers. In addition, the company offers testing services for crop protection agents and tobacco constituents in seed, leaf, and finished products, including e-cigarette liquids and vapors; and analytical services that include chemical compound testing in finished tobacco products and mainstream smoke. Further, it provides a various value-added manufacturing processes to produce specialty vegetable and fruit-based ingredients for the food and beverage end markets, as well as provides water pipe style leaf tobacco; and recycles waste materials from tobacco production. The company was founded in 1886 and is headquartered in Richmond, Virginia.
Latest RKDA
- SEC Form 10-Q filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
- Amendment: SEC Form 10-K/A filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- SEC Form 10-K filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights
- SEC Form EFFECT filed by Arcadia Biosciences Inc.
- Arcadia Biosciences Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
Latest UVV
- Senior VP & COO Hentschke Airton L covered exercise/tax liability with 9,485 shares, decreasing direct ownership by 7% to 128,193 units (SEC Form 4) to satisfy withholding obligation
- Chairman, President & CEO Wigner Preston Douglas covered exercise/tax liability with 2,461 shares, decreasing direct ownership by 2% to 103,928 units (SEC Form 4) to satisfy withholding tax
- VP, Gen. Counsel & Secretary Claiborne Catherine H covered exercise/tax liability with 1,277 shares, decreasing direct ownership by 4% to 28,241 units (SEC Form 4) (for tax liability)
- Senior VP & Sales Director Starke Mckeen covered exercise/tax liability with 733 shares, decreasing direct ownership by 9% to 7,603 units (SEC Form 4) (withholding obligation)
- VP, Ingredients O'Keefe John Patrick covered exercise/tax liability with 1,685 shares, decreasing direct ownership by 10% to 16,038 units (SEC Form 4) (tax withholding)
- VP & Controller Bleicher Scott J covered exercise/tax liability with 882 shares, decreasing direct ownership by 5% to 17,072 units (SEC Form 4) (withholding obligation)
- Senior VP & CFO Diel Steven S. covered exercise/tax liability with 248 shares, decreasing direct ownership by 0.83% to 29,577 units (SEC Form 4) (withholding obligation)
- SEC Form 10-K filed by Universal Corporation
- Universal Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Universal Corporation Reports Fiscal Year and Fourth Quarter 2026 Results